...
首页> 外文期刊>Journal of Pharmacy and Bioallied Sciences >Comparison between branded and generic furosemide 40 mg tablets using thermal gravimetric analysis and Fourier transform infrared spectroscopy
【24h】

Comparison between branded and generic furosemide 40 mg tablets using thermal gravimetric analysis and Fourier transform infrared spectroscopy

机译:品牌和通用呋塞米的比较40毫克使用热重分析和傅里叶变换红外光谱法

获取原文
           

摘要

Background and Purpose: There has been a long-standing belief that generic drugs are of lower value in comparison to their branded name counterparts. They are in particular under scrutiny due to their low market price. Even though the reduction in costs is largely based on skipping expensive preclinical studies and clinical trials for generic drugs, the purity and quality of the raw materials in the production of generic drugs is debatable. Thus, the objective of the study was to analyze and assess the quality comparability of generic furosemide 40 mg (FSD) tablets to branded product available in the market. Materials and Methods: Quality control tests, in vitro drug release assessments, and thermal analysis investigations for both analog products of FSD were performed. Various physical parameters related to the tablet quality, such as hardness, weight variation, and friability tests, were examined. In vitro drug release behavior evaluations were conducted according to United States Pharmacopeia (USP) specifications and guidelines, whereas thermal analysis was carried out using thermal gravimetric analysis (TGA), and tablets were further evaluated by Fourier transform infrared (FTIR) spectroscopy. Results: The results indicated a significant variation between the two products in terms of hardness, weight variation, and friability. This could be correlated to variation appeared in thermal and spectroscopic spectra between the two products using TGA and FTIR. Drug release of FSD was slightly different between both products following incubation in different pH media (1.2, 3.0, and 6.5; 120 min), however, this was in accordance with USP dissolution requirements as 80% of drug release was obtained within the first 30 min from each product. Conclusion: This study is a useful example for the independent investigations using thermal and spectroscopic analysis to confirm potential hidden variations between generic and branded products that could not be obtained by the bioequivalence studies.
机译:背景和目的:与他们的品牌名称同行相比,通用药物的价值较低。由于他们的市场价格低,它们尤其涉及审查。尽管成本的降低主要是基于跳过昂贵的临床前研究和普通药物的临床试验,但普通药物生产中原材料的纯度和质量是难题的。因此,该研究的目的是分析和评估通用呋塞米(FSD)片剂的质量可比性(FSD)片剂在市场上可用的品牌产品。材料和方法:进行质量控制试验,体外药物释放评估和FSD两种模拟产品的热分析研究。检查与平板电脑质量相关的各种物理参数,如硬度,重量变化和脆性测试。根据美国药典(USP)规范和指南进行体外药物释放行为评估,而使用热重分析(TGA)进行热分析,并且通过傅里叶变换红外(FTIR)光谱评估片剂。结果:结果表明两种产品在硬度,重量变化和脆性方面的显着变化。这可以与使用TGA和FTIR之间的两种产品之间的热和光谱光谱中出现的变化相关。在不同pH培养基(1.2,3.0和6.5; 120分钟)孵育后,FSD的药物释放在孵育后的两种产品之间略有不同,但这符合USP溶解要求,因为在第一个中获得<80%的药物释放每种产品30分钟。结论:本研究是使用热和光谱分析的独立调查的有用示例,以确认通过生物等效性研究无法获得的通用和品牌产品之间的潜在隐藏变化。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号